On 8 June 2021, the Swiss Agency for Therapeutic Products issued a press release announcing the results of Operation PANGEA XIV. Authorities worldwide have been checking for criminal online sales of medicines in a coordinated operation: The week from 18 to 25 May saw a coordinated worldwide campaign against the illegal online trade in medicines.
On 9 June 2021, the Swiss Government announced that the Federal Customs Administration and the Federal Customs Service of the Russian Federation signed a memorandum of understanding on customs cooperation in Moscow on 9 June 2021.
The Global Financial Institutions Industry Podcast includes 13 episodes on the following topics: Operational Risk, Risk Management Guidelines, Fintech, Financial Institutions, Insurtech, Insurance and Financial Sponsors.
The Medical Device Regulation (“MDR”) enters into force in the EU. As from that date, the Mutual Recognition Agreement (“MRA”) between Switzerland and the EU no longer applies to trade in medical devices. To avoid a ban on imports, the Swiss Federal Government on 19 May 2021 adopted contingency rules providing for a grace period and clarifying the rules that medical devices need to meet for continued import into Switzerland.
On March 31, 2021, the Swiss government amended the list of individuals in Annex 1 to the Ordinance on…
Since the ICO boom in 2017, governments around the world began settling on different approaches to regulating the…
In brief As readers of JIBFL will be well aware, it is expected that LIBOR will no longer be available after the end of 2021, with the exception of certain tenors for USD LIBOR that will be published until the end of June 2023 and, potentially, a synthetic LIBOR for…
COVID-19 represents one of the greatest ever shocks to our economies and, in consequence, to the business models…
With less than three months to go before the EU Sustainable Finance Disclosure Regulation (SFDR) comes into force on 10 March 2021, this recorded webinar covers the practical steps that firms should be taking now to comply, with a focus on how UK and other non-EU firms can navigate scope issues and the expectations of EU-based clients, investors, and regulators. It focuses in particular on the governance, documentation and data collation steps that firms should be taking now, and the way in which we expect market approach to develop over the next 12-24 months. We also cover the direction of travel in the UK and Switzerland in relation to ESG, green taxonomies, and TCFD compliance. We are joined on this webinar by ECO:FACT, a data-driven ESG advisory firm that has been helping clients understand environmental and human rights risk since 1998
The pandemic has impacted our lives in many ways, but for many of us, one of the most affected areas has certainly been work. COVID-19 has indeed led to an unprecedented need and demand for remote working. In recent months, many people have been forced or have chosen to work…